Jordan Green, professor of biomedical engineering and faculty member at the Institute for NanoBioTechnology (INBT), was named one of the National Academy of Medicine’s (NAM) Emerging Leaders in Health and Medicine. Together with the other 19 Emerging Leaders, he will collaborate with NAM members and other experts to shape the Academy’s priorities and advance knowledge and progress in science, medicine, policy, and health equity.

Selected by NAM leadership, participants in the Emerging Leaders program include early- to mid-career professionals from a wide range of health-related fields such as basic and translational science, clinical medicine, bioengineering, federal health policy and law, and ethics.

“These exceptional individuals were selected to the National Academy of Medicine’s Emerging Leaders in Health and Medicine program for their leadership attributes and because they are poised to shape the future of health and medicine,” said NAM President Victor J. Dzau. “I look forward to engaging these impressive individuals, who are the next generation of scientists, health care providers, public health professionals, and policymakers, to develop a network of young leaders and catalyze innovative and cross-disciplinary activities addressing some of the most pressing challenges in health and medicine.”

Over a three-year term, program participants will engage in a variety of activities throughout the National Academies of Sciences, Engineering, and Medicine (National Academies), such as planning the inaugural NAM Emerging Leaders Forum. Scheduled for April 11-12, 2019, in Washington D.C., the forum will provide an opportunity for collaborative work and interdisciplinary discussions among the nation’s evolving leadership in health and medicine.

Additional Emerging Leaders program activities will include attending biannual meetings with NAM leadership; participating in National Academies convening activities, including standing committees, roundtables, workshop planning committees, and report review panels; publishing NAM Perspectives; and attending the NAM’s annual meeting each October.

Green is also a member of the Translational Tissue Engineering Center at Johns Hopkins University. His research focuses on the design and development of biotechnologies and advanced therapeutics for drug and gene delivery.

This announcement was adapted from the original article that appeared on the Johns Hopkins Biomedical Engineering Department website. 

Story by: Sarah Tareny, Department of Biomedical Engineering